Skip to content

Clinical trials

Terminated Phase 2 Inflammation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Status: Terminated Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20052
20071
20081
20091
20101
20111
20124
20131
20143
20151
20162
20171
20182
20191
20204
20214
20222
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Novo Nordisk A/S3
National Institute of Nursing Research (NINR)2
Novartis Pharmaceuticals2
AM-Pharma1
Aaron Ritter, MD1
Alcon Research1
Ashvattha Therapeutics, Inc.1
Charles Drew University of Medicine and Science1
Critical Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation39
Alzheimer Disease4
Arthritis, Rheumatoid4
Arthritis, Juvenile2
Cognitive Dysfunction2
Coronavirus Infections2
Crohn Disease2
Cytokine Release Syndrome2
Dementia2
Infections2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.